Amit Bar-or

26 4e 16

Melissa and Paul Anderson President's Distinguished Professor

7 60

Department: Neurology

4 1 23

1f Graduate Group Affiliations 8

Neuroscience

46 Contact information
45

Department of Neurology
4a 3400 Spruce Street – 3 Gates Building
Philadelphia, PA 19104

2e Office: 215-662-3606
32 Fax: 215-662-3362
24

Email:
amitbar@pennmedicine.upenn.edu

4 3 3 1d

18 Publications
23

5b 6f

26 Search PubMed for articles c

3 2 29

Links
a7 Search PubMed for articles
d

4 b 1f

13 Education:
21 8 BSc 23 (Biology and Psychology) c
2c McMaster University, 1988.
21 7 MD 15 (Medicine) c
2a McGill University, 1993.
c

3 3 3 3 92 Permanent link
2 29

b6 > Perelman School of Medicine > Faculty > Details a

1e 1d

2b 29

Selected Publications

11d Ghadiri M, Rezk A, Li R, Evans A, Luessi F, Zipp F, Giacomini PS, Antel J: Dimethyl fumarate-induced lymphopenia in MS due to differential T-cell subset apoptosis. Neurol Neuroimmunol Neuroinflamm 4(3), Mar 2017.

77 Aubert-Broche B, Weier K, Longoni G, Fonov VS, Bar-Or A, Marrie RA, Yeh EA, 75 Narayanan S, Arnold DL, Verhey LH, Banwell B, Collins DL; : Monophasic demyelination reduces brain growth in 37 children Neurology April 2017.

1d8 Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L: OPERA I and OPERA II Clinical Investigators. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis. N Engl J Med. 376(3): 221-234, Jan 2017.

1c9 Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky J: ORATORIO Clinical Investigators. Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis. N Engl J. 376(3): 221-234, Jan 2017.

139 Li R, Rezk A, Ghadiri M, Luessi F, Zipp F, Li H, Giacomini PS, Antel J, Bar-Or A*: Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis. J Immunol. 198(2): 691--698, Jan 2017.

18d Rozenberg A, Rezk A, Boivin MN, Darlington PJ, Nyirenda M, Li R, Jalili F, Winer R, Artsy EA, Uccelli A, Reese JS, Planchon SM, Cohen JA, Bar-Or A: Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid-Dependent Mechanism. Stem Cells Transl Med. pii: sctm.2015-0243(11), Jul 2016.

1a0 Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, Moore C, Michel L, Althekair F, Rajasekharan S, Gommerman J, Prat A, Fillatreau S and Bar-Or A on behalf of the 'Canadian B cells in MS Team': Proinflammatory GM-CSF producing B cells: implication in multiple sclerosis and B cell depletion therapy. Sci Transl Med 7(310): 166, Oct 2015.

175 Makhani N, Banwell B, Tellier R, Yea C, McGovern S, O'Mahony J, Ahorro JM, Arnold D, Sadovnick AD, Marrie RA, Bar-Or A; Canadian Pediatric Demyelinating Disease Network: Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination. Mult Scler 22(3): 385-8, Mar 2016.

134 Bar-Or A, Wiendl H, Miller B, Benamor M, Truffinet P, Church M, Menguy-Vacheron F: Randomized study of teriflunomide effects on immune responses to neo-antigen and recall antigens. Neurol Neuroimmunol Neuroinflamm. 2(2): e70, Feb 2015.

14c Moore CS, Cui QL, Warsi NM, Durafourt BA, Zorko N, Owen DR, Antel JP, and Bar-Or A: Direct and Indirect Effects of Immune and Central Nervous System–Resident Cells on Human Oligodendrocyte Progenitor Cell Differentiation. J Immunol 194(2): 761-72, Jan 2015.

2c

7 1d

2c back to top
26 Last updated: 10/05/2021
34 The Trustees of the University of Pennsylvania c

1 49 2 12